glp 1 glp PDB-101: Molecule of the Month: GLP-1 Receptor Agonists 1 experience.GLP How GLP-1 medications are transforming

The dose Dr

FDA issued a total of 303 warning letters issued in FY25 to drug and biologics manufacturers

For type 2 diabetes , NICE NG28 recommends continuing GLP-1 treatment only if there is adequate response, defined as HbA1c reduction of at least 11 mmol/mol (1.0%) and weight loss of at least 3% of initial body weight at 6 months

Whole, minimally processed foods aren't just a good idea in general

Willems M, Quartero AO, Numans ME

The global GLP-1 Weight Loss Drug Market was valued at USD 68.65 billion in 2026 and is projected to reach USD 195.01 billion by 2035 , growing at a CAGR of 12.3% during the 20262035 forecast period